Mandate

Investor buys out part of Neoventa Medical

July 21, 2006

Investor Growth Capital and CapMan are investing in Neoventa Medical AB, a Swedish medical technology company in the field of fetal monitoring. Investor Growth Capital and CapMan will hold approximately 30% each of the share capital, while the majority of the remaining shares will be owned by SEK Företagsinvest as previous. The new ownership constellation provides the company with SEK 75 million to finance the next phase in Neoventa's growth - focusing on the American market.

Vinge acted as advisor to Neoventa Holding AB. Vinge representatives included Johan Winnerblad, Marcus Axelryd and Theresa Kovac.

Related

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.
July 10, 2025

Vinge advises Main Capital in connection with the sale of Alfa eCare

Vinge has advised Main Capital in connection with the sale of Alfa eCare Holding AB and its subsidiaries (“Alfa eCare”) to SDB Groep B.V. (“SDB”)
July 10, 2025

Vinge is advising on the establishment of Ballista Capital

Ballista Capital held its final closing on 9 June 2025. The investor base primarily comprises family offices and investors with strong ties to northern Sweden.
July 07, 2025